CNSX:TAAT

Empower Clinics Stock Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Empower Clinics (CNSX:TAAT) Vs. ATD.A, ATD.B, WN, DOL, MRU, and EMP.A

Should you be buying Empower Clinics stock or one of its competitors? The main competitors of Empower Clinics include Alimentation Couche-Tard (ATD.A), Alimentation Couche-Tard (ATD.B), George Weston (WN), Dollarama (DOL), Metro (MRU), and Empire (EMP.A). These companies are all part of the "tobacco" industry.These companies are all part of the "tobacco" industry.These companies are all part of the "consumer defensive" sector.These companies are all part of the "consumer defensive" sector.

Empower Clinics (CNSX:TAAT) and Alimentation Couche-Tard (TSE:ATD.A) are both consumer defensive companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.

Valuation & Earnings

This table compares Empower Clinics and Alimentation Couche-Tard's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Empower ClinicsN/AN/AN/AN/AN/A
Alimentation Couche-TardC$49.63 billion1.05C$3.35 billionC$3.1215.55

Alimentation Couche-Tard has higher revenue and earnings than Empower Clinics.

Profitability

This table compares Empower Clinics and Alimentation Couche-Tard's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Empower ClinicsN/AN/AN/A
Alimentation Couche-TardN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for Empower Clinics and Alimentation Couche-Tard, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Empower Clinics00103.00
Alimentation Couche-Tard0000N/A

Empower Clinics presently has a consensus target price of $5.37, indicating a potential upside of ∞. Given Empower Clinics' higher possible upside, equities analysts clearly believe Empower Clinics is more favorable than Alimentation Couche-Tard.

Summary

Empower Clinics beats Alimentation Couche-Tard on 2 of the 3 factors compared between the two stocks.

Empower Clinics (CNSX:TAAT) and Alimentation Couche-Tard (TSE:ATD.B) are both consumer defensive companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.

Valuation & Earnings

This table compares Empower Clinics and Alimentation Couche-Tard's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Empower ClinicsN/AN/AN/AN/AN/A
Alimentation Couche-TardC$49.63 billion1.04C$3.35 billionC$3.1215.46

Alimentation Couche-Tard has higher revenue and earnings than Empower Clinics.

Profitability

This table compares Empower Clinics and Alimentation Couche-Tard's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Empower ClinicsN/AN/AN/A
Alimentation Couche-TardN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for Empower Clinics and Alimentation Couche-Tard, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Empower Clinics00103.00
Alimentation Couche-Tard03622.91

Empower Clinics presently has a consensus target price of $5.37, indicating a potential upside of ∞. Alimentation Couche-Tard has a consensus target price of C$56.60, indicating a potential upside of 17.23%. Given Empower Clinics' stronger consensus rating and higher possible upside, equities analysts clearly believe Empower Clinics is more favorable than Alimentation Couche-Tard.

Summary

Alimentation Couche-Tard beats Empower Clinics on 3 of the 5 factors compared between the two stocks.

Empower Clinics (CNSX:TAAT) and George Weston (TSE:WN) are both consumer defensive companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.

Valuation & Earnings

This table compares Empower Clinics and George Weston's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Empower ClinicsN/AN/AN/AN/AN/A
George WestonC$55.30 billion0.36C$623.34 millionC$4.1431.97

George Weston has higher revenue and earnings than Empower Clinics.

Profitability

This table compares Empower Clinics and George Weston's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Empower ClinicsN/AN/AN/A
George WestonN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for Empower Clinics and George Weston, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Empower Clinics00103.00
George Weston01402.80

Empower Clinics presently has a consensus target price of $5.37, indicating a potential upside of ∞. George Weston has a consensus target price of C$137.83, indicating a potential upside of 4.17%. Given Empower Clinics' stronger consensus rating and higher possible upside, equities analysts clearly believe Empower Clinics is more favorable than George Weston.

Empower Clinics (CNSX:TAAT) and Dollarama (TSE:DOL) are both consumer defensive companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.

Valuation & Earnings

This table compares Empower Clinics and Dollarama's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Empower ClinicsN/AN/AN/AN/AN/A
DollaramaC$4.15 billion4.22C$581.83 millionC$1.9230.14

Dollarama has higher revenue and earnings than Empower Clinics.

Profitability

This table compares Empower Clinics and Dollarama's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Empower ClinicsN/AN/AN/A
DollaramaN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for Empower Clinics and Dollarama, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Empower Clinics00103.00
Dollarama02612.89

Empower Clinics presently has a consensus target price of $5.37, indicating a potential upside of ∞. Dollarama has a consensus target price of C$62.36, indicating a potential upside of 7.71%. Given Empower Clinics' stronger consensus rating and higher possible upside, equities analysts clearly believe Empower Clinics is more favorable than Dollarama.

Summary

Dollarama beats Empower Clinics on 3 of the 5 factors compared between the two stocks.

Empower Clinics (CNSX:TAAT) and Metro (TSE:MRU) are both consumer defensive companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, analyst recommendations, profitability, institutional ownership, risk, dividends and earnings.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Empower Clinics and Metro, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Empower Clinics00103.00
Metro08002.00

Empower Clinics currently has a consensus price target of $5.37, suggesting a potential upside of ∞. Metro has a consensus price target of C$65.80, suggesting a potential upside of 9.83%. Given Empower Clinics' stronger consensus rating and higher probable upside, equities analysts plainly believe Empower Clinics is more favorable than Metro.

Earnings & Valuation

This table compares Empower Clinics and Metro's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Empower ClinicsN/AN/AN/AN/AN/A
MetroC$18.33 billion0.80C$800.10 millionC$3.2818.28

Metro has higher revenue and earnings than Empower Clinics.

Profitability

This table compares Empower Clinics and Metro's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Empower ClinicsN/AN/AN/A
MetroN/AN/AN/A

Summary

Empower Clinics beats Metro on 3 of the 4 factors compared between the two stocks.

Empower Clinics (CNSX:TAAT) and Empire (TSE:EMP.A) are both consumer defensive companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, earnings, profitability, valuation and dividends.

Profitability

This table compares Empower Clinics and Empire's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Empower ClinicsN/AN/AN/A
EmpireN/AN/AN/A

Earnings and Valuation

This table compares Empower Clinics and Empire's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Empower ClinicsN/AN/AN/AN/AN/A
EmpireC$28.62 billion0.36C$687.77 millionC$2.5915.00

Empire has higher revenue and earnings than Empower Clinics.

Analyst Recommendations

This is a summary of current ratings and target prices for Empower Clinics and Empire, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Empower Clinics00103.00
Empire03402.57

Empower Clinics currently has a consensus target price of $5.37, suggesting a potential upside of ∞. Empire has a consensus target price of C$45.56, suggesting a potential upside of 17.29%. Given Empower Clinics' stronger consensus rating and higher probable upside, research analysts plainly believe Empower Clinics is more favorable than Empire.


Empower Clinics Competitors List

Competitor NameBTM RankShare PriceAnalysts' Price TargetMarket CapRevenueP/E RatioEmployee CountIndicator(s)
Alimentation Couche-Tard logo
ATD.A
Alimentation Couche-Tard
1.4$48.55
flat
N/AC$52.00 billionC$49.63 billion15.55130,000
Alimentation Couche-Tard logo
ATD.B
Alimentation Couche-Tard
1.8$48.28
flat
$56.60
flat
C$51.71 billionC$49.63 billion15.46130,000
George Weston logo
WN
George Weston
1.7$132.31
flat
$137.83
flat
C$19.93 billionC$55.30 billion31.97226,299
Dollarama logo
DOL
Dollarama
1.7$57.90
flat
$62.36
flat
C$17.54 billionC$4.15 billion30.148,440
Metro logo
MRU
Metro
1.5$59.91
flat
$65.80
flat
C$14.62 billionC$18.33 billion18.2890,000
Empire logo
EMP.A
Empire
2.3$38.84
flat
$45.56
flat
C$10.31 billionC$28.62 billion15.00125,000
The North West logo
NWC
The North West
2.1$34.29
flat
$38.25
flat
C$1.65 billionC$2.23 billion11.436,939
Jamieson Wellness logo
JWEL
Jamieson Wellness
1.7$36.63
flat
$41.34
flat
C$1.47 billionC$434.76 million33.33110
Lassonde Industries logo
LAS.A
Lassonde Industries
1.8$180.07
flat
$195.00
flat
C$1.25 billionC$1.95 billion14.232,200
SunOpta logo
SOY
SunOpta
1.9$11.36
flat
$15.35
flat
C$1.22 billionC$807.13 million13.211,451
Village Farms International logo
VFF
Village Farms International
1.7$11.27
flat
$25.33
flat
C$964.31 millionC$213.17 million-142.66900
Rogers Sugar logo
RSI
Rogers Sugar
1.8$5.59
flat
$5.45
flat
C$579.61 millionC$896.91 million13.871,243Dividend Announcement
News Coverage
Clearwater Seafoods Incorporated (CLR.TO) logo
CLR
Clearwater Seafoods Incorporated (CLR.TO)
1.7N/A$8.25
flat
C$536.82 millionC$507.11 million86.741,845
Corby Spirit and Wine logo
CSW.A
Corby Spirit and Wine
1.2$17.90
flat
N/AC$509.60 millionC$159.78 million16.73175
High Liner Foods logo
HLF
High Liner Foods
2.2$13.25
flat
$16.88
flat
C$443.04 millionC$826.26 million9.87N/A
AGT Food and Ingredients logo
AGT
AGT Food and Ingredients
0.9N/AN/AC$436.02 millionC$1.55 billion-8.102,200High Trading Volume
Andrew Peller logo
ADW.A
Andrew Peller
1.6$8.65
flat
$15.00
flat
C$377.75 millionC$386.99 million19.011,398
Fire & Flower logo
FAF
Fire & Flower
1.4$0.90
flat
$1.85
flat
C$309.52 millionC$163.73 million-2.8819,597
Waterloo Brewing logo
WBR
Waterloo Brewing
1.3$7.08
flat
$8.42
flat
C$253.23 millionC$103.97 million50.21240High Trading Volume
BABY
Else Nutrition
1.6$2.43
flat
$6.50
flat
C$233.53 millionC$3.22 million-10.801,729Gap Up
Brick Brewing logo
BRB
Brick Brewing
1.1N/AN/AC$127.78 millionC$55.42 million41.98164Gap Down
OGO
Organto Foods
1.1$0.44
flat
N/AC$112.58 millionC$17.82 million-11.7627
MAV Beauty Brands logo
MAV
MAV Beauty Brands
2.2$2.14
flat
$4.83
flat
C$83.96 millionC$113.28 million7.9993News Coverage
WTER
Alkaline Water
1.0$1.28
flat
N/AC$75.50 millionC$37.04 million-3.7914News Coverage
Input Capital logo
INP
Input Capital
1.4$0.87
flat
N/AC$52.95 millionC$15.95 million41.4324Gap Up
TPK
Swiss Water Decaffeinated Coffee
1.5N/AN/AC$49.84 millionC$86.49 million18.03N/A
HEMP
Hempco Food and Fiber
0.9$0.68
flat
N/AC$43.95 millionC$2.23 million-5.44N/AGap Down
BR
Big Rock Brewery
1.6$5.85
flat
$10.00
flat
C$40.44 millionC$47.42 million-2,925.0012,000Positive News
DWS
Diamond Estates Wines & Spirits
1.3$0.17
flat
$0.22
flat
C$33.00 millionC$26.99 million-12.69109High Trading Volume
FRN
Feronia
0.7$0.04
flat
N/AC$29.04 millionC$29.65 million-0.288,000
GreenSpace Brands logo
JTR
GreenSpace Brands
1.0$0.07
flat
N/AC$28.93 millionC$19.29 million-1.3077Gap Up
SWP
Swiss Water Decaffeinated Coffee
0.1$3.03
flat
N/AC$27.66 millionC$103.83 million-303.0079
GLG
GLG Life Tech
1.2$0.20
flat
N/AC$7.54 millionC$12.53 million1.2525Gap Down
SNF
Sunora Foods
1.1$0.15
flat
N/AC$6.08 millionC$14.12 million-150.00N/AGap Down
VPI
Vitality Products
1.1$0.12
flat
N/AC$4.76 millionC$825,015.00-16.43N/APositive News
Gap Down
CYF
Canyon Creek Food
0.9$0.09
flat
N/AC$2.99 millionC$7.47 million-1.18N/AGap Up
CHN
China Education Resources
0.7$0.05
flat
N/AC$2.13 millionC$8.31 million-11.25N/AUpcoming Earnings
Gap Up
VGM
Global Gardens Group
0.9$0.02
flat
N/AC$2.00 millionC$514,712.00-0.52N/AGap Up
AGRO
Adecoagro
0.8N/AN/A$0.00N/A0.008,716High Trading Volume
EATS
Eat Beyond Global
1.0N/AN/A$0.00N/A0.00147,000News Coverage
High Trading Volume
LXX
Lexaria Bioscience
1.0N/AN/A$0.00N/A0.00N/A
TNY
Tinley Beverage
1.0N/AN/AC$0.00N/A0.00N/AGap Down
High Trading Volume
This page was last updated on 9/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.